Image result for brain tissue biobank

Tissue Bio-Banking

A tissue biobanking service is provided under the direction of Prof Elaine Kay and Dr. Tony O’Grady. This biobank comprises fresh frozen and formalin-fixed tumour and normal breast, colon, prostate and skin tissue samples. An important aim of the tissue biobank is to ensure the availability of high quality, well annotated tissue specimens for research. It underpins ongoing and future translational research projects.

The cancer biobank is managed by clinical research nurse, Joan Kehoe. Her role currently encompasses screening patients for involvement in our studies in the Gastro Intestinal clinic and following them through to surgery. Clinico-pathological data including tumour grade, stage, and vascular invasion status along with disease specific survival data has been collected prospectively is also maintained by the Clinical Research Nurse.

Brain Tumor Biobank

With the support from Brain Tumour Ireland, the RCSI Centre for Systems Medicine (CSM) along with the Departments of Neurosurgery and Neuropathology in Beaumont Hospital have established a brain tumor biobank in RCSI and Beaumont Hospital. In the future, every patient undergoing brain tumour surgery will be given the opportunity to consent to have their tissue included in the biobank. This collaboration will enable the CSM RCSI Principal Investigators, Dr. Brona Murphy, Dr. Amanda Tivnan and Prof. Jochen Prehn and their teams to analyse and develop novel therapies for the treatment of brain tumors.Brain Tumour Ireland is delighted to support RCSI (Royal College of Surgeons in Ireland) in the establishment of its brain tumour biobank, which will encourage research aimed at individualised treatments and increasing survival rates for brain tumour patients.By collecting brain tumour cells from patients, the biobank will enable new and targeted therapies for brain tumours to be examined in the lab using these cells. Only patients who consent can have their tissue used in the biobank, and only tissue surplus to diagnostic requirements can be biobanked.